Navigation Links
New Drug Fights Anthrax Toxin
Date:7/8/2009

olunteers and could be used in a clinical setting in cases of life-threatening inhalation anthrax disease, Bolmer said.

Under a contract with U.S. Biomedical Advanced Research and Development Authority, the company has delivered 20,000 doses of raxibacumab to the U.S. Strategic National Stockpile for emergency use. Approval of the drug by the U.S. Food and Drug Administration is pending, Bolmer said.

Mingtao Zeng, an assistant professor in the department of microbiology and immunology at the University of Rochester Medical Center, said this study has provided solid data to support raxibacumab as a new candidate drug for biodefense and public health.

"The most encouraging finding is that raxibacumab appeared to be safe and well-tolerated, with reasonably high doses in the phase 1 human clinical trial, which had 333 healthy human volunteers," Zeng said. "I anticipate that raxibacumab can be used as a short-term prophylactic agent for protection against anthrax or as a therapeutic drug in combination with antibiotics for effective treatment of anthrax."

Dr. Gary Nabel, director of the Vaccine Research Center at the U.S. National Institute of Allergy and Infectious Diseases and author of an accompanying journal editorial, said the paper shows that the antibody can block infection in animals and similar levels of the drug can be safely given to people.

"It therefore satisfies the criteria of the animal rule, a regulatory guideline used to approve drugs for diseases that can't be tested for efficacy in humans," Nabel said.

This antibody provides a new tool to control anthrax infection and "if approved, could be stockpiled as a countermeasure against this potential public health threat," he said.

"This paradigm of drug approval for biodefense agents provides a new way to address such threats, though questions remain about how and when to use such drugs and how to incentivize industry to produce th
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Guacamole: Fights Hunger, Cholesterol and Cancer
2. Two-Drug Combo Fights Brain Tumors
3. Connecticut Girl Fights Rare Neurological Disease
4. Experimental Drug Fights Prostate Cancer
5. New Drug Fights Medication-Linked Bone Loss
6. MIT radar technology fights breast cancer
7. Drug fights cystic fibrosis
8. USAID Fights Neglected Tropical Diseases
9. Mothers & More Fights to End Invisimomibility
10. Dr. Lance H. Brown President-Elect of Dermatologic Society of Greater New York Fights Misconceptions About Sun Protection and Skin Care in Support of Skin Cancer Awareness Month - May
11. Fish diet to avoid fights
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug Fights Anthrax Toxin  
(Date:7/10/2014)... New York, US (PRWEB) July 10, 2014 ... . , Merrill DataSite recently streamed the live webinar ... featuring a discussion from a group of several M&A ... are seeing in the broader energy transaction marketplace. These ... hot and how the deal market in this sector ...
(Date:7/10/2014)... A Forever Recovery , an ... off to a great start and gives them a ... launched a new Eating Disorders section of its website ... , Different types of eating disorders ... Disorders (DSM-IV), including anorexia nervosa, bulimia nervosa, and EDNOS ...
(Date:7/10/2014)... July 10, 2014 (HealthDay News) -- Nature, not nurture, ... of individual chimpanzees, a new study finds. "As ... comes to cognitive [thinking] abilities in chimpanzees," William Hopkins ... said in a news release from the journal ... insight into the evolution of intelligence in humans, Hopkins, ...
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Men who have a ... cancer, a new study suggests. But the risk ... not involved with the study said more research is ... accurate. For the study, Harvard researchers analyzed data ... for 24 years, starting in 1986. During that time, ...
(Date:7/10/2014)... aggression, who research issues ranging from child abuse to ... of the International Society for Research on Aggression (ISRA) ... State University is hosting the prestigious world meeting, which ... "We are excited to be bringing together leading scholars ... produce fresh ideas about the causes, consequences and solutions ...
Breaking Medicine News(10 mins):Health News:Register to Download Merrill DataSite's Report: Capitalizing on the Shifting Sands of the Energy Market 2Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2Health News:Like Humans, Chimps' Smarts May Rely on Genes 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3
... Mothers who are depressed respond differently to their crying ... according to brain scans at the University of Oregon, ... in non-depressed moms. An infant crying is normal, ... says Jennifer C. Ablow, professor of psychology. For years, ...
... This release is available in Spanish . ... and cooperators have confirmed what many pollen-sensitive people already suspected: ... longer and ends later. Ragweed pollen in some ... almost a month longer than it did in 1995, and ...
... , TUESDAY, Feb. 22 (HealthDay News) -- Despite suggestions ... skin condition known as atopic eczema, a new British ... to relieve sufferers. "Although the outcome is disappointing ... eczema, the outcome of the trial is very clear," ...
... HealthDay Reporter , TUESDAY, Feb. 22 (HealthDay News) -- ... increased risk of ischemic stroke, which typically occurs when blood ... fatty deposits within blood vessels, a new Danish study contends. ... pronounced for triglyceride fats than it is for cholesterol, even ...
... researcher believes there could be a new drug compound ... also help with controlling cholesterol. Salman Hyder, the ... biomedical sciences in the College of Veterinary Medicine and ... discovered that a small molecule, Ro 48-8071, initially developed ...
... leap forward in understanding Huntington,s disease may give patients ... cells and post-mortem brain tissue of Huntington,s disease patients ... that causes brain nerve cells to die. Toning down ... the chain reaction and kept those cells alive, according ...
Cached Medicine News:Health News:Crying baby draws blunted response in depressed mom's brain 2Health News:Crying baby draws blunted response in depressed mom's brain 3Health News:USDA study confirms links between longer ragweed season and climate change 2Health News:Softening Water Does Not Seem to Ease Eczema 2Health News:High Triglyceride Levels Linked to Increased Stroke Risk: Study 2Health News:High Triglyceride Levels Linked to Increased Stroke Risk: Study 3Health News:Compound used to block cholesterol could also kill breast cancer, MU researcher finds 2Health News:Huntington's disease breakthrough equals hope for patients 2
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced it ... adults suffering from the severe cold weather that has gripped ... to helping those in need; so to support these emergency ... up to $250,000, which could mean up to $500,000 in ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide ... from the Journal of Drugs in Dermatology ... Conference (ODAC). The event is January 17-20, 2014, at the Omni ... . The ODAC is a distinguished ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... against cancers and infectious diseases, announced today that the ... technology at the 14th Annual Meeting of the American ... May 18-21 in Seattle, Washington at the Washington State ...
... Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" ... first quarter ended March 31, 2011. F ... Highlights Total revenue increased to $9.4 million ... Net cash provided by operating activities was approximately $2.6 ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 2Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 3Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 4China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 2China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 3China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 4China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 5China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 6China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 7China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 8
... interoperative placement to stent the ... and continent urinary diversions. Supplied ... for one-time use. CAUTION: Periodic ... not remain indwelling more than ...
... a device that provides effective cutting and simultaneous ... to provide the urologist with the same touch ... the approximate speed and the same ease of ... but with a 45% greater zone of ...
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: